Journals / Uludağ Üniversitesi Tıp Fakültesi Dergisi / 2023 / Cilt: 49 Sayı: 2

Emphysmatous Pyelonephritis: Case Report

Amfizematöz Piyelonefrit: Olgu Sunumu

Orçun Burak Karadağ(Ankara Etlik Şehir Hastanesi, Üroloji Kliniği, Ankara.)0000-0002-4073-8283
Mehmet Altan(Ankara Etlik Şehir Hastanesi, Üroloji Kliniği, Ankara.)0000-0002-0504-3988
Nihat Karakoyunlu(Ankara Etlik Şehir Hastanesi, Üroloji Kliniği, Ankara.)0000-0002-6680-9860
Alihan Kokurcan(Ankara Etlik Şehir Hastanesi, Üroloji Kliniği, Ankara.)0000-0003-3486-108X
Adem Sancı(Ankara Etlik Şehir Hastanesi, Üroloji Kliniği, Ankara.)0000-0003-2229-8234
Ahmet Emin Doğan(Ankara Etlik Şehir Hastanesi, Üroloji Kliniği, Ankara.)0000-0002-0670-3044
Pages
277–281
Publication Date
2023-09-08
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In our case, we aimed to present the clinical details of the amphizematous pyelonephritis patient, who was treated primarily with conservative methods in our clinic but then nephrectomy, the treatment process followed and the results of the process.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Emphysmatous pyelonephritis is a serious pyelonephritis of a necrotizing type associated with life-threatening, very high renal loss and mortality, which is developed in immunocompromised (mostly diabetic patients) and patients with urinary obstruction.
📊
Key Findings & Data:Emphysmatous pyelonephritis is a serious pyelonephritis of a necrotizing type associated with life-threatening, very high renal loss and mortality, which is developed in immunocompromised (mostly diabetic patients) and patients with urinary obstruction.
💡
Conclusion & Impact:In our case, we aimed to present the clinical details of the amphizematous pyelonephritis patient, who was treated primarily with conservative methods in our clinic but then nephrectomy, the treatment process followed and the results of the process.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:böbrek · piyelonefrit · amfizematöz piyelonefrit

Abstract

Emphysmatous pyelonephritis is a serious pyelonephritis of a necrotizing type associated with life-threatening, very high renal loss and mortality, which is developed in immunocompromised (mostly diabetic patients) and patients with urinary obstruction. In our case, we aimed to present the clinical details of the amphizematous pyelonephritis patient, who was treated primarily with conservative methods in our clinic but then nephrectomy, the treatment process followed and the results of the process.

Özet

Amfizematöz piyelonefrit, bağışıklığı baskılanmış (çoğunlukla diyabetik hastalarda) ve üriner obstrüksiyonu olan hastalarda gelişen, hayatı tehdit eden, çok yüksek oranda böbrek kaybı ve mortalite ile ilişkili nekrotizan tipte ciddi bir piyelonefrittir. Yazımızda, kliniğimizde öncelikle konservatif yöntemler ile tedavi edilen fakat sonrasında nefrektomi yapılan amfizematöz piyelonefrit hastasının klinik detaylarını, izlenilen tedavi sürecini ve sürecin sonuçlarını sunmayı hedefledik.

🔖

Cite This Article

Karadağ, O. B., Altan, M., Karakoyunlu, N., Kokurcan, A., Sancı, A., Doğan, A. E., *, O. B. K. (2023). Emphysmatous Pyelonephritis: Case Report. Uludağ Üniversitesi Tıp Fakültesi Dergisi, Cilt: 49 Sayı: 2, 277–281. https://doi.org/10.32708/uutfd.1320768

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Ciccarese F, Brandi N, Corcioni B, Golfieri R, Gaudiano C. Complicated pyelonephritis associated with chronic renal stone disease. Radiol Med. 2021 Apr;126(4):505-516. doi: 10.1007/s11547-020-01315-7. Epub 2020 Nov 27. PMID: 33245481; PMCID: PMC8007507.
  2. Nicola R, Menias CO. Üriner Obstrüksiyon, Taş Hastalığı ve Enfeksiyon. 2018 Mart 21. Gelen: Hodler J, Kubik-Huch RA, von Schulthess GK, editörler. Karın ve Pelvis Hastalıkları 2018-2021: Teşhis Görüntüleme IDKD Kitabı [İnternet]. Cham (CH): Springer; 2018. Bölüm 20.
  3. Wu SY, Yang SS, Chang SJ, Hsu CK. Emphysematous pyelonephritis: classification, management, and prognosis. Tzu Chi Med J. 2022 Apr 13;34(3):297-302. doi: 10.4103/tcmj.tcmj_257_21. PMID: 35912050; PMCID: PMC9333110.
  4. Deoraj S, Zakharious F, Nasim A, Missouris C. Emphysematous pyelonephritis: outcomes of conservative management and literature review. BMJ Case Rep. 2018 Sep 12;2018:bcr2018225931. doi: 10.1136/bcr-2018-225931. PMID: 30209146; PMCID: PMC6144252.
  5. Bultitude, Matthew F. "Campbell‐Walsh Urology Tenth Edition." (2012): E10-E10.
  6. Mongha R, Punit B, Ranjit DK, Anup KK. Amfizematözpiyelonefrit – Olgu sunumu ve radyolojik özelliklerindeğerlendirilmesi. Suudi J Böbrek Dis Nakli. 2009; 20:838–41
  7. Huang J, TsengC.Emphysematous Pyelonephritis: Clinicoradiological Classification, Management, Prognosis, and Pathogenesis. Arch Intern Med. 2000; 160(6):797–805. doi:10.1001/archinte.160.6.797
  8. Mohsin N, Budruddin M, Lala S, Al-Taie S. Emphysematouspyelonephritis: a case report series of four patients with reviewof literature. Ren Fail 2009;31(7):597-601